Word

TERREMOTO

Status

Pending

Status Code

681

Status Date

Thursday, April 18, 2024

Serial Number

97697582

Mark Type

3

Filing Date

Wednesday, November 30, 2022

Published for Opposition

Tuesday, May 21, 2024

Trademark Owner History

TERREMOTO BIOSCIENCES, INC. - 1st New Owner Before Publication

Classifications

5 Pharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceuticals for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; biopharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; biopharmaceuticals for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; medicines for the prevention and treatment of cancer, oncological diseases, disorders and conditions; medicines for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; drugs for the prevention and treatment of cancer, oncological diseases, disorders and conditions; drugs for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; drug compounds for the prevention and treatment of cancer, oncological diseases, disorders and conditions; drug compounds for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; small molecules for the prevention and treatment of cancer, oncological diseases, disorders and conditions; small molecules for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; therapeutics for the prevention and treatment of cancer, oncological diseases, disorders and conditions; therapeutics for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions;

42 Drug discovery and development services; computational drug discovery and development services; scientific, medical, biotechnology, biomedical, medicinal chemistry, and pharmaceutical research and development services; scientific and medical testing services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; research, development, discovery and consulting services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; research in the fields of chemistry and medicinal chemistry; medical research; clinical research and development services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; medical and scientific research, namely, conducting and evaluating clinical trials for others; providing information about medical and scientific research; providing scientific information in the fields of medicine, biotechnology, medicinal chemistry, and pharmaceuticals; provision of drug discovery and development information; provision of computational drug discovery information;

The English translation of "TERREMOTO" in the mark is "Earthquake".

Trademark Events

Dec 3, 2022

New Application Entered

Dec 22, 2022

New Application Office Supplied Data Entered

Sep 9, 2023

Assigned To Examiner

Oct 19, 2023

Application Extension To Response Period - Received

Mar 13, 2024

Teas/Email Correspondence Entered

Mar 13, 2024

Correspondence Received In Law Office

Mar 13, 2024

Teas Response To Office Action Received

Apr 17, 2024

Approved For Pub - Principal Register

May 1, 2024

Notification Of Notice Of Publication E-Mailed

Oct 19, 2023

Application Extension Granted/Receipt Provided

Dec 23, 2022

Notice Of Design Search Code E-Mailed

Jan 25, 2023

Automatic Update Of Assignment Of Ownership

Sep 16, 2023

Non-Final Action Written

Sep 16, 2023

Non-Final Action E-Mailed

Sep 16, 2023

Notification Of Non-Final Action E-Mailed